In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
The price of Ventyx Biosciences Inc (NASDAQ: VTYX) closed at $8.19 in the last session, down -3.65% from day before closing price of $8.5. In other words, the price has decreased by -$3.65 from its previous closing price. On the day, 0.78 million shares were traded. VTYX stock price reached its highest trading level at $8.51 during the session, while it also had its lowest trading level at $8.055.
Ratios:
We take a closer look at VTYX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 17.86 and its Current Ratio is at 17.86. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.05.
On March 12, 2024, Wells Fargo Upgraded its rating to Overweight which previously was Equal Weight and also upped its target price recommendation from $7 to $16.
Oppenheimer Upgraded its Perform to Outperform on March 12, 2024, while the target price for the stock was maintained at $12.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Apr 02 ’25 when Nuss John sold 1,887 shares for $1.07 per share. The transaction valued at 2,019 led to the insider holds 467,226 shares of the business.
Nuss John sold 21,119 shares of VTYX for $49,841 on Dec 27 ’24. The CHIEF SCIENTIFIC OFFICER now owns 464,582 shares after completing the transaction at $2.36 per share. On Dec 27 ’24, another insider, Nuss John, who serves as the Officer of the company, bought 21,119 shares for $2.36 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VTYX now has a Market Capitalization of 584427200 and an Enterprise Value of 401813248.
Stock Price History:
The Beta on a monthly basis for VTYX is 1.23, which has changed by 2.7777777 over the last 52 weeks, in comparison to a change of 0.13613915 over the same period for the S&P500. Over the past 52 weeks, VTYX has reached a high of $10.55, while it has fallen to a 52-week low of $0.78. The 50-Day Moving Average of the stock is 11.66%, while the 200-Day Moving Average is calculated to be 143.05%.
Shares Statistics:
According to the various share statistics, VTYX traded on average about 4.29M shares per day over the past 3-months and 1964670 shares per day over the past 10 days. A total of 71.34M shares are outstanding, with a floating share count of 64.07M. Insiders hold about 10.21% of the company’s shares, while institutions hold 62.17% stake in the company. Shares short for VTYX as of 1764288000 were 5424203 with a Short Ratio of 1.26, compared to 1761868800 on 6149971. Therefore, it implies a Short% of Shares Outstanding of 5424203 and a Short% of Float of 8.08.
Earnings Estimates
The stock of Ventyx Biosciences Inc (VTYX) is currently being evaluated by 7.0 analysts who are actively contributing to its market rating.The consensus estimate for the next quarter is -$0.37, with high estimates of -$0.27 and low estimates of -$0.51.
Analysts are recommending an EPS of between -$1.35 and -$1.57 for the fiscal current year, implying an average EPS of -$1.44. EPS for the following year is -$1.61, with 7.0 analysts recommending between -$1.14 and -$2.1.
